Preventive Effect of Cow's Milk Fermented With Lactobacillus Paracasei CBA L74 on Common Infectious Diseases in Children

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

September 15, 2022

Primary Completion Date

January 10, 2024

Study Completion Date

January 11, 2024

Conditions
Upper Respiratory Tract InfectionsGastrointestinal InfectionChildren, Only
Interventions
DIETARY_SUPPLEMENT

milk fermented with lactobacillus paracasei CBA L74

milk fermented with lactobacillus paracasei CBA L74 will be administered daily for 3 months to 100 children. Participants were supplied with the milk product in powder form, by Heinz Italia SpA, Segrate, Italy. The study products were provided in tins containing 400 g of powder, and the packaging was similar and the tins were stored at room temperature in a dry environment. The family pediatricians instructed parents about the daily amount of the assigned study product and the method of preparation. All subjects received 7 g/day of study products diluted in a maximum of 150 mL of cow's milk or water. After dilution, the look and the taste were the same for all of the study products.

DIETARY_SUPPLEMENT

placebo milk formula

placebo milk formula containing maltodextrins will be administered daily for 3 months to 100 children. The study products were provided in tins containing 400 g of powder, and the packaging was similar and the tins were stored at room temperature in a dry environment. The family pediatricians instructed parents about the daily amount of the assigned study product and the method of preparation. All subjects received 7 g/day of study products diluted in a maximum of 150 mL of cow's milk or water. After dilution, the look and the taste were the same for all of the study products.

Trial Locations (1)

70125

Clinica Pediatrica, Bari

All Listed Sponsors
collaborator

Heinz Italia SpA

INDUSTRY

lead

University of Bari

OTHER